April 9, 2019 | Patient-centric, clinical trials, health literacy, patient focus
For those unfamiliar with them, clinical trials can be rather bewildering. This presents problems when it comes to recruiting patients — how can we make sure they understand what they are signing up for?
In our new white paper, Liz Walder and Sarah Gracey, Cuttsy+Cuttsy’s Scientific Team Leader and Senior Graphic Designer, share what we have learned in our many years of creating clinical trials materials for healthcare professionals and patients. Click here to download a copy and learn about removing some of the mystery around clinical trials.
Click here to download a copy and learn about removing some of the mystery around clinical trials
Company Details
Latest Content from Cuttsy + Cuttsy
Patients are often most honest outside the clinic—revealing vital insights that can help clinical trial teams build trust, improve participation and collect better data.
Patient-relevant outcomes sit at the heart of the EU HTA reforms, but ensuring they reflect lived experience requires you to look beyond what traditional clinical endpoints measure.
Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at the table.
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.
A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.
Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.
Learn what good localisation looks like in clinical trials and why participant-facing materials should feel naturally relevant, culturally appropriate and easy to understand across every market.
